A.R.T. Advisors’s Sucampo Pharmaceuticals SCMP Stock Holding History
Bought
Maintained
Sold
Other funds holding SCMP
A.R.T. Advisors's SCMP Position: Q2 2017 in Review
A.R.T. Advisors sold out of Sucampo Pharmaceuticals (SCMP) in Q2 2017, closing a stake of 108,100 shares — an estimated $1.19M sold.
A.R.T. Advisors first reported a position in SCMP in Q2 2013 and held it in 10 quarters. The position peaked at $1.19M in Q1 2017. 167 funds tracked by Wall St. Rank hold SCMP as of Q2 2017.
- A.R.T. Advisors reported no remaining Sucampo Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
- A.R.T. Advisors sold 108,100 Sucampo Pharmaceuticals shares in Q2 2017, an estimated $1.19M.
- A.R.T. Advisors first reported a position in Sucampo Pharmaceuticals in Q2 2013 and held it in 10 quarters.
- A.R.T. Advisors's Sucampo Pharmaceuticals position peaked at $1.19M in Q1 2017.
- 167 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals as of Q2 2017.
Based on A.R.T. Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.